VERNALIS
LIVE

Serial Number

86591321

Owner

VERNALIS (R&D) LIMITED

Attorney

Mainak H. Mehta

Filing Date

Apr 8, 2015

Add to watchlist:

No watchlists yet
View on USPTO

VERNALIS Trademark

Serial Number: 86591321 • Registration: 4891901

VERNALIS is a trademark filed by VERNALIS (R&D) LIMITED on April 8, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

VERNALIS (R&D) LIMITED (23 trademarks)

100 BERKSHIRE PLACE, WHARFEDALE ROAD
WINNERSH, WOKINGHAM, BERKSHIRE RG41 5RD , GB

Entity Type: 03

Vernalis Development Limited (6 trademarks)

Cambridge CB216GB

Entity Type: 03

Trademark Details

Filing Date

April 8, 2015

Registration Date

January 26, 2016

Published for Opposition

November 10, 2015

Goods & Services

[ Pharmaceutical and veterinary preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; Sanitary preparations for medical purposes; Dietetic food and substances for medical or veterinary use in the nature of pasta, breads, cereals, crackers, meat, fruit, vegetables, confectionery, lipids in the nature of margarine, butter substitute, lard, fish oil, butter, peanut oil, soya bean oil, sunflower oil, sesame oil, coconut oil, olive oil, animal-derived fats and oils, plant-derived oils and dairy products in the nature of cheese, milk, butter, yoghurt, cream, and curds, all adapted for medical use; dietary supplements for humans and animals; chemical reagents for medical or veterinary purposes; chemical medical reagents for therapeutic and diagnostic purposes; chemico-pharmaceutical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medical chemical preparations for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders; medicines for the treatment and prophylaxis of infections by a bacterial, viral or fungal agent in skin infections, infections of major organs, ear, nose and throat infections, respiratory infections, subcutaneous infections, blood infections, cerebral infections and sexually transmitted infections, neurological and psychological disorders, nervous system diseases and disorders, migraines, headaches, coughs, colds, allergies and respiratory diseases, gastro-intestinal disorders, circulatory disorders, dermatological conditions, organ damage, cell proliferation, blood disorders, pain, cancers, women's health issues in the nature of medical conditions relating to reproduction disorders, conception disorders, pregnancy and contraception disorders, menstrual disorders, post-menopausal disorders, sexual function disorders, female hormone disorders, osteoporosis and breast cancer, uterine and ovarian cancer, men's health issues in the nature of reproduction disorders, conception disorders, contraception disorders, prostate disorders, testes disorders, male hormone disorders, alopecia, sexual function disorders, prostate cancer, testicular cancer and impotence, endocrinology disorders, pediatrics issues in the nature of mental health disorders, diabetes and endocrinology disorders, gastroenterology disorders, herpetology disorders, immunology disorders, skin infections, and allergies, nephology disorders, neurodisability disorders, neurology disorders, oncology disorders, respiratory disorders, rheumatology disorders, dermatology disorders, cardiology disorders, geriatrics issues in the nature of clinical, preventative, remedial and social aspects of illness in the elderly in the nature of immobility disorders, incontinence disorders, mental health disorders, strokes, heart disease, infectious diseases, diabetes, delirium, syncope, cerebral aging and Parkinsonism, and inflammation disorders ]

Scientific and technological services, namely, pharmaceutical product evaluation, development and testing services; industrial analysis and research services in the nature of pharmaceutical product evaluation, development and testing services; biotechnology research; chemical research; research consulting in the field of pharmaceutical product evaluation, development and testing services; scientific, medical and clinical research and development in the nature of pharmaceutical product evaluation, development and testing services; research and development in the nature of pharmaceutical product evaluation, development and testing services; laboratory research services relating to pharmaceuticals; pharmaceutical research; medical and scientific laboratory services; laboratory testing services in the field of pharmaceutical product evaluation, development and testing services; testing of pharmaceuticals; chemical analysis; technological research in the nature of pharmaceutical product evaluation, development and testing services; conducting product evaluations in the field of new pharmaceuticals; inspection of pharmaceuticals; pharmaceutical product evaluation; pharmaceutical drug development services

Filing History

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 26, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 10, 2022 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 10, 2022 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 10, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Dec 21, 2021 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 16, 2021 COAR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 30, 2021 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 16, 2021 ASGN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 19, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 19, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 19, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 19, 2021 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 26, 2021 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 26, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 10, 2015 NPUB
PUBLISHED FOR OPPOSITION
Nov 10, 2015 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 21, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 5, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 2, 2015 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 1, 2015 XAEC
ASSIGNED TO LIE
Oct 1, 2015 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 1, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 1, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 1, 2015 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 23, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jul 23, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jul 23, 2015 CNRT
ASSIGNED TO EXAMINER
Jul 15, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2015 NWOS
NEW APPLICATION ENTERED
Apr 11, 2015 NWAP